LOSORDO DOUGLAS W 4
4 · CALADRIUS BIOSCIENCES, INC. · Filed Apr 10, 2018
Insider Transaction Report
Form 4
LOSORDO DOUGLAS W
Chief Medical Officer
Transactions
- Award
Performance Rights
2018-04-06+13,300→ 13,300 total→ Common Stock (13,300 underlying)
Footnotes (2)
- [F1]Each performance right represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The performance criteria was satisfied on April 6, 2018 and the performance right shall vest in full on the date of stockholder approval of a new or amended equity plan provided that such approval is obtained on or prior to August 30, 2018 and if not obtained by such date this performance right shall terminate (the "Vesting Date").